Monotherapy with risperidone is effective and well tolerated in acute and continuation treatment of mania. The results should be confirmed in randomized, double-blind clinical trials.
Ross J. Baldessarini, John Hennen, Michael G. Wilson, Joseph R. Calabrese, Roy Chengappa, Paul E. Keck, Susan L. McElroy, Gary Sachs, Eduard Vieta, Jeffrey A. Welge, Lakshmi N. Yatham, Carlos A. Zarate, Robert W. Baker, Mauricio Tohen
Discussion(0)
No comments yet. Be the first to comment.